Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of Envarsus® (formerly ...
Tags: Veloxis Pharmaceuticals, New Drug Application, Envarsus®
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised an option to conduct the investigational new drug (IND) enabling program and to submit an IND. ...
Tags: BioCryst, NIAID, investigational new drug, BCX4430, Marburg virus disease
The United States no longer leads the world in biomedical research; it fell from 51 percent in 2007 to 45 percent in 2012, but Asia spent more, researchers say. The study, published in the New England Journal of Medicine, found U.S. ...
Tags: Health, Medicine, Biomedical Research
Among different surgical procedures, gastric bypass was more effective for weight loss but was associated with more complications, U.S. researchers say. Su-Hsin Chang of the Washington University School of Medicine in St. Louis and ...
For patients with herniated discs in the lower (lumbar) spine, surgery leads to greater long-term improvement in pain, functioning, and disability compared to nonsurgical treatment, concludes an eight year follow-up study in Spine. The ...
Tags: herniated discs, long-term improvement, Spine, lumbar disc herniation
Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of critically ill patients, announced today that its investor group and employee shareholders ...
Tags: Ikaria, sell the Commercial Business, Madison Dearborn Partners
The French maker of a drug used to treat multiple sclerosis is "extremely disappointed" it was rejected for U.S. sale, a corporate official said. David Meeker, president of Sanofi's Genzyme subsidiary, maker of the drug Lemtrada, said he ...
In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breastfeeding to do so, at ...
Probiotics -- friendly bacteria found in supplements and some yogurts -- don't prevent childhood asthma, but they may provide other health benefits, according to a new study. Researchers in Canada found that taking probiotics during ...
Tags: probiotics, childhood asthma, friendly bacteria, yogurt
A safe and effective male birth control pill may be inching closer to reality, according to researchers. In laboratory experiments, mouse sperm was blocked from semen while still allowing for normal sexual activity. Without sperm in the ...
Tags: male birth control, male birth control pill, birth control pills
Low levels of vitamin D have been implicated as a potential cause of diseases ranging from cancer to diabetes. Now an extensive review suggests it's really the other way around: Low levels of the "sunshine vitamin" are more likely a ...
Tags: vitamin D, cancer, diabetes, low levels of vitamin D
Food and Drug Administration said Monday that it wants makers of antibacterial hand soaps and body washes to prove their products are safe for long-term daily use and more effective than regular soaps in preventing illness and the spread of ...
Tags: antibacterial hand soaps, body washes, FDA
Obese children who don't have type 2 diabetes but take the diabetes drug metformin while improving their diet and exercise habits seem to lose a bit of weight. But it isn't much more weight than kids who only make the lifestyle changes, ...
Tags: obese children, type 2 diabetes, diabetes drug, metformin, loss weight
Drug labels often lack infant-specific information, despite U.S. government legislation encouraging drug studies involving children, a new study finds. The research focused on neonates, who are infants up to 28 days of age. They are at ...
Tags: drug labels, infant-specific information, drug studies, neonates
Anoro Ellipta (umeclidinium and vilanterol inhalation powder) has been approved by the U.S. Food and Drug Administration for once-daily treatment of chronic obstructive pulmonary disease (COPD). COPD, an umbrella term that includes the ...
Tags: Anoro Ellipta